Challenges to Biomarker Testing for PD-1/PD-L1 Checkpoint Inhibitors for Lung Cancer.
我要评论
本期排行
- Uniform Labeling of Blocks and...
- Challenges to Biomarker Testin...
- Mammary Hibernoma: A Rare Enti...
- Edoxaban: Efficacy, Laboratory...
- Pathology Education: Moving On...
- Who Will Do My Autopsy?
- The Differential Diagnosis of ...
- Updates on Surgical and Molecu...
- Telepathology Impacts and Impl...
- Clinical Applications of 4-Fac...
共0条评论